Prognostic Impact of Negative Serum (1,3)-β-D-glucan in Patients With Candidemia
Clin Infect Dis
.
2020 Aug 14;71(4):1124-1126.
doi: 10.1093/cid/ciz1051.
Authors
Daniele Roberto Giacobbe
1
2
,
Marco Berruti
1
2
,
Malgorzata Mikulska
1
2
Affiliations
1
Dipartimento di Scienze della Salute, University of Genoa, Genoa, Italy.
2
Clinica Malattie Infettive, Istituto di Ricovero e Cura a Carattere Scientifico, Ospedale Policlinico San Martino, Genoa, Italy.
PMID:
31665246
DOI:
10.1093/cid/ciz1051
No abstract available
Publication types
Letter
Comment
MeSH terms
Adult
Candidemia* / diagnosis
Candidemia* / drug therapy
Glucans
Humans
Prognosis
Proteoglycans
Tertiary Care Centers
beta-Glucans*
Substances
Glucans
Proteoglycans
beta-Glucans
polysaccharide-K